By the end of the presentation, participants will be able to:
1) understand the dynamics of implementing an integrated viral hepatitis program in long-term residential drug treatment settings; and
2) understand the methods used to achieve successful utilization of hepatitis vaccination and screening services.
Substance use/abuse is a common cofactor in the transmission of viral hepatitis. CDC's National Hepatitis C Prevention Strategy recommends targeting participants in drug treatment programs for viral hepatitis intervention. Effective service delivery methods need to be explored, particularly those that leverage private, public, and nonprofit resources.
Participants were adults (n=951) admitted to six long-term residential drug treatment programs in South Florida.
Population e.g. API Youth, MSM, IDU:
Adults in residential drug treatment programs.
Hep-C ALERT, a community-based organization, developed the Addiction Recovery Hepatitis Intervention Project (ARHIP) to evaluate the feasibility of delivering viral hepatitis services to clients in long-term residential drug treatment programs. Goals were to increase viral hepatitis education, prevention, testing, and medical referral. ARHIP is a collaboration between a community-based organization, two health departments, and six residential drug treatment sites.
Nearly 99% of clients admitted to the drug treatment programs were enrolled in ARHIP. HCV testing was accomplished in 84% of participants, and 81% received at least one dose of HAV and/or HBV vaccine. Ninety-four percent of those still in residence at the time received a second dose of hepatitis B vaccine. Clients positive for HCV were referred for additional care with 27% accessing care during the intervention tracking period. The degree to which specific collaboration and implementation objectives were met will be discussed in the presentation. Conclusions: A collaborative approach to integrate viral hepatitis education, prevention, counseling, and testing into the long-term residential drug treatment setting is feasible and well-received by clients.
See more of H6 - Models of Hepatitis Vaccination in Substance Abuse Treatment Settings
See more of The 2005 National Viral Hepatitis Prevention Conference